Skip to main content
. 2020 Nov 5;12(11):3278. doi: 10.3390/cancers12113278

Figure 2.

Figure 2

Evaluation of cellular viability in HeLa, UD-SCC-2, and VX2 cells. Cellular viability was assessed with the MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide) assay to determine the dark toxicity and phototoxicity of curcumin-loaded liposomes (A, B, and C left) and free curcumin using dimethyl sulfoxide (DMSO) as a vehicle (A, B, and C right). Dark toxicity and phototoxicity were determined by incubation of curcumin liposomes and free curcumin (in DMSO) for 4 h in the concentration range of 0–100 µmol/L at light fluences of 1, 3, and 5 J·cm−2. Dark refers to untreated cells (0 µmol/L curcumin) and cells treated with free curcumin (in DMSO) or curcumin liposomes without photodynamic therapy (PDT). The half maximal inhibitory concentration (IC50) values were calculated by nonlinear curve fitting for each light fluence. All samples were measured in triplicate, and the data are expressed as mean ± standard deviation. Statistical significances are indicated as *** p < 0.001, ** p < 0.01. § denotes that the viability of cells treated with free curcumin (in DMSO) is significantly (p < 0.001) lower than in the corresponding curcumin (liposomes)-treated cells.